Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1213998C details a novel route for antifolate intermediates using stable sulfonic acid salts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Efficient fragment-based SPPS method for Nangibotide offering high purity and scalable manufacturing solutions for global pharmaceutical partners seeking reliable supply.
Advanced synthesis of Nifuratel avoiding hazardous reagents. Cost-effective pharmaceutical intermediates manufacturing with improved safety and scalability.
Patent CN114773316A details a scalable Grignard-based route for 2-(2,6-dioxo-piperidin-3-yl)-5-fluoro-isoindole-1,3-dione, offering high purity and cost-effective manufacturing for PROTAC intermediates.
Patent CN113683566A details a novel solvent-free synthesis of Edaravone achieving >99% purity. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN1098272C reveals a novel ether-silyl protection strategy for clarithromycin, offering high selectivity and cost reduction in antibiotic manufacturing for global supply chains.
Patent CN104086487B reveals ionic liquid method for caprolactam. Reduces waste and cost. Reliable supply chain solution for polymer and pharma intermediates.
Patent CN112795603B reveals a high-efficiency IRED method for chiral pyrrolidines, offering superior purity and green manufacturing advantages.
Patent CN103387556A details a safer synthetic route for alpha-acetyl-gamma-butyrolactone, eliminating hazardous reagents while achieving yields over 85%.
Patent CN116903499B reveals a novel anhydrous copper salt synthesis enabling cost reduction in pharmaceutical intermediate manufacturing and high-purity trifluoromethylation.
Advanced patent CN106045970A details high-yield Efinaconazole intermediate production with reduced impurities and scalable mild conditions for supply chain stability.
Novel two-step route offers high purity pharmaceutical intermediates with reduced costs and scalable production capabilities for global supply chains ensuring reliability.
Patent CN101701243B details a high-efficiency biocatalytic route for R-mandelic acid using Alcaligenes faecalis, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116023401B reveals mild photoredox synthesis for chiral borates. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Advanced Wittig reaction protocol for high-purity cephalosporin intermediates. Optimized Z-isomer selectivity and scalable manufacturing for oral antibiotics.
Patent CN116023401B reveals mild photoredox nickel catalysis for chiral borates. Enables high purity pharmaceutical intermediates with reduced cost and scalable supply chain reliability.
Advanced solvent exchange crystallization for Ezetimibe intermediates ensuring over 99 percent purity and ee value for global pharmaceutical supply chains.
Patent CN102964337A details a novel alkaline oxidation route for Esomeprazole, offering superior optical purity and cost-effective manufacturing for global pharmaceutical supply chains.
Novel recovery method for L-camphorsulfonic acid resolving agent ensuring high purity and yield over 89 percent for cost-effective Clopidogrel manufacturing.
Advanced synthesis of DL-neopentyl glycine via glycylglycine acetylation. High-purity amino acid intermediate for pharma. Cost-effective scalable production.